CREBBP and acute lymphoblastic leukemia: As with other B-ALL subtypes, patients with near-haploid B-ALL have recurrent disruption, by deletion, insertion-deletions or point mutations, of the lysine acetyltransferase gene CREBBP (32% of patients) [30].